论文部分内容阅读
目的:评价乳糖酸阿奇霉素治疗小儿支气管炎临床疗效。方法:选择2016年3月-2017年4月来我院治疗小儿支气管炎的患儿80例作为研究对象,通过随机信封法将其分为观察组和对照组均40例。对照组采用常规治疗,观察组在常规治疗基础上增加乳糖酸阿奇霉素治疗,对比分析两组患儿临床症状改善时间、肺功能指标、临床治疗有效率。结果:观察组临床症状改善时间明显低于对照组(P<0.05),肺功能指标明显优于对照组(P<0.05),且临床治疗有效率明显高于对照组(P<0.05)。结论:在小儿支气管炎临床治疗中,给予乳糖酸阿奇霉素治疗,既可减少临床症状改善时间,改善肺功能,又可提高临床治疗有效率,值得临床推广应用。
Objective: To evaluate the clinical efficacy of azithromycin lactobionate in the treatment of pediatric bronchitis. Methods: Eighty children with bronchiolitis in our hospital from March 2016 to April 2017 were selected as the research object. They were divided into observation group and control group by random envelope method in 40 cases. The control group was treated with conventional therapy. The observation group was treated with azithromycin lactobionate on the basis of routine treatment. The clinical symptoms improvement time, lung function indexes and clinical treatment efficiency were compared between the two groups. Results: The clinical symptom improvement time in the observation group was significantly lower than that in the control group (P <0.05). The pulmonary function indexes were significantly better than those in the control group (P <0.05). The effective rate of clinical treatment was significantly higher than that of the control group (P <0.05). Conclusion: In the clinical treatment of children with bronchitis, given lactobionate azithromycin treatment, both to reduce the clinical symptoms and improve the time to improve lung function, but also improve the efficiency of clinical treatment, it is worth promoting the clinical application.